Sign In
Buy SESN
$0.629
+0 (+0%)
At Close: Jun 06, 2023
Boston, Massachusetts--(Newsfile Corp. - August 27, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations
New York, New York--(Newsfile Corp. - August 27, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securiti
New York, New York--(Newsfile Corp. - August 27, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZY, ANVS and SESN
05:40am, Friday, 27'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 27, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to partic
New York, New York--(Newsfile Corp. - August 26, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Sesen Bio, Inc. (NASDAQ: SESN
San Francisco, California--(Newsfile Corp. - August 26, 2021) - Hagens Berman urges Sesen Bio, Inc. (NASDAQ: SESN) investors with losses in excess of $250,000 to submit your losses now.Class Period:
SESN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Sesen Bio, Inc.
03:50pm, Thursday, 26'th Aug 2021
New York, New York--(Newsfile Corp. - August 26, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Sesen Bio, Inc
After FDA Rejection Troubled Biotech Pulls Europe Application For Bladder Cancer Drug
02:48pm, Thursday, 26'th Aug 2021
Two weeks ago, Sesen Bio Inc (NASDAQ: SESN) was on the cusp of winning FDA approval for the cancer drug Vicineum. It was working toward authorization in Europe.
LOS ANGELES, Aug. 26, 2021 /PRNewswire/ -- Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sesen Bio, Inc. ("Sesen Bio" or "the Co
New York, New York--(Newsfile Corp. - August 26, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sesen Bio, Inc. (NASDAQ: SESN) alleging
New York, New York--(Newsfile Corp. - August 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
Sesen Shareholder Alert
06:14pm, Wednesday, 25'th Aug 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sesen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp
Berman Tabacco Announces that Investors with Substantial Losses in Sesen Bio, Inc. May Seek Appointment as Lead Plaintiff
04:09pm, Wednesday, 25'th Aug 2021
Boston, Massachusetts--(Newsfile Corp. - August 25, 2021) - The Massachusetts office of Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations
SHAREHOLDER ALERT: Robbins LLP Announces that Sesen Bio, Inc. (SESN) is Being Sued for Misleading Shareholders
01:13pm, Wednesday, 25'th Aug 2021
SAN DIEGO--(BUSINESS WIRE)---- $SESN #BIO--Shareholder rights law firm Robbins LLP announces that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Se
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 18, 2021 to
